Retrospective Study
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Sep 26, 2021; 9(27): 8061-8070
Published online Sep 26, 2021. doi: 10.12998/wjcc.v9.i27.8061
Endu combined with concurrent chemotherapy and radiotherapy for stage IIB-IVA cervical squamous cell carcinoma patients
Feng-Ju Zhao, Qun Su, Wei Zhang, Wen-Cui Yang, Lin Zhao, Li-Ying Gao
Feng-Ju Zhao, Qun Su, Wei Zhang, Wen-Cui Yang, Lin Zhao, Li-Ying Gao, Department of Radiotherapy, Gansu Cancer Hospital, Lanzhou 730050, Gansu Province, China
Author contributions: Zhao FJ and Su Q design the experiment; Zhang W drafted the work, Yang WC, Zhao L and Gao LY collected the data; Zhao FJ and Su Q analysed and interpreted data, Zhang W, Zhao FJ and Gao LY wrote the article.
Institutional review board statement: This study was approved by the Gansu Cancer Hospital Ethics Committee.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare that there is no conflict of interest between them.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:
Corresponding author: Li-Ying Gao, MD, Chief Doctor, Department of Radiotherapy, Gansu Cancer Hospital, No. 2 Xiaoxihu East Street, Qilihe District, Lanzhou 730050, Gansu Province, China.
Received: May 18, 2021
Peer-review started: May 18, 2021
First decision: June 15, 2021
Revised: June 29, 2021
Accepted: August 3, 2021
Article in press: August 3, 2021
Published online: September 26, 2021
Core Tip

Core Tip: Through a set of retrospective studies, it was confirmed that the combination of Endo combined with radiotherapy and chemotherapy for the treatment of advanced cervical squamous cell carcinoma has a positive effect on reducing the level of tumor markers in patients and prolonging the survival time of patients.